Page 1 | Search Results | Blood | American Society of Hematology

1-12 of 12

Sort by

Sort Order Select

Journal Articles

Pegaspargase Can Safely be Administered in Adults Age 40 and Older with Acute Lymphoblastic Leukemia

Ryan J. Daley, PharmD, Sridevi Rajeeve, MD, Charlene C. Kabel, PharmD, Jeremy J. Pappacena, PharmD, BCOP, Sarah E. Stump, PharmD, BCPS, BCOP, Jessica A. Lavery, MS, Martin S. Tallman, MD, Mark B. Geyer, MD, Jae H. Park, MD

Blood (2019) 134 (Supplement_1): 3816.

https://doi.org/10.1182/blood-2019-124727

Published: 2019

Journal Articles

Risk of Hyponatremia and Associated Clinical Characteristics in Patients with Acute Lymphoblastic Leukemia after CD19 Targeted Chimeric Antigen Receptor (CAR) T-Cells

Brianne N. Dixon, PharmD, Ryan J. Daley, PharmD, BCOP, Troy Z. Horvat, PharmD, BCOP, Larry W Buie, PharmD, BCOP, FASHP, Meier Hsu, MS, Sheron Latcha, MD, Renier J. Brentjens, MD PhD, Jae H. Park, MD

Blood (2017) 130 (Supplement 1): 3584.

https://doi.org/10.1182/blood.V130.Suppl_1.3584.3584

Published: 2017

Journal Articles

Biomarkers for Predicting Toxicity and Response in Adult Acute Lymphoblastic Leukemia (ALL) Patients Treated with Blinatumomab

Amber C. King, PharmD, BCOP, Ryan J. Daley, PharmD, BCOP, Troy Z. Horvat, PharmD, BCOP, Meier Hsu, MS, Jae H. Park, MD

Blood (2017) 130 (Supplement 1): 3883.

https://doi.org/10.1182/blood.V130.Suppl_1.3883.3883

Published: 2017

Journal Articles

Venetoclax Combined with Either a Hypomethylating Agent or Low-Dose Cytarabine Shows Activity in Relapsed and Refractory Myeloid Malignancies

Aaron D Goldberg, MD, Troy Z. Horvat, PharmD, BCOP, Meier Hsu, MS, Sean M. Devlin, PhD, Bernadette M. Cuello, BSN, MSN, NP, RN, Ryan J. Daley, PharmD, BCOP, Amber C. King, PharmD, BCOP, Larry W Buie, PharmD, BCOP, FASHP, Jacob L Glass, MDPhD, Michael J. Mauro, MD, Eytan M. Stein, MD, Ellin Berman, MD, Virginia M. Klimek, MD, Martin S. Tallman, MD

Blood (2017) 130 (Supplement 1): 1353.

https://doi.org/10.1182/blood.V130.Suppl_1.1353.1353

Published: 2017

Journal Articles

Erwinia Asparaginase Safety and Feasibility during Therapy for Acute Lymphoblastic Leukemia in Adult Patients with Pegaspargase Hypersensitivity or Severe Toxicity

Troy Z Horvat, PharmD, BCOP, Joshua J Pecoraro, PharmD, BCOP, Ryan J Daley, PharmD, BCOP, Larry W Buie, PharmD, BCOP, Dan Douer, MD

Blood (2015) 126 (23): 4915.

https://doi.org/10.1182/blood.V126.23.4915.4915

Published: 2015

Journal Articles

Prediction of graft-versus-host disease by phenotypic analysis of early immune reconstitution after CD6-depleted allogeneic bone marrow transplantation

RJ Soiffer, R Gonin, C Murray, MJ Robertson, K Cochran, S Chartier, C Cameron, J Daley, H Levine, LM Nadler

Blood (1993) 82 (7): 2216–2223.

https://doi.org/10.1182/blood.V82.7.2216.2216

Published: 1993

Journal Articles

Autologous and allogeneic bone marrow transplantation for poor prognosis patients with B-cell chronic lymphocytic leukemia

SN Rabinowe, RJ Soiffer, JG Gribben, H Daley, AS Freedman, J Daley, K Pesek, D Neuberg, G Pinkus, PR Leavitt

Blood (1993) 82 (4): 1366–1376.

https://doi.org/10.1182/blood.V82.4.1366.1366

Published: 1993

Journal Articles

Follicular dendritic cells inhibit human B-lymphocyte proliferation

AS Freedman, JM Munro, K Rhynhart, P Schow, J Daley, N Lee, J Svahn, L Eliseo, LM Nadler

Blood (1992) 80 (5): 1284–1288.

https://doi.org/10.1182/blood.V80.5.1284.1284

Published: 1992

Journal Articles

Clonal analysis of T-cell deficiencies in autotransplant recipients

RA Miller, J Daley, R Ghalie, H Kaizer

Blood (1991) 77 (8): 1845–1850.

https://doi.org/10.1182/blood.V77.8.1845.1845

Published: 1991

Journal Articles

Reconstitution of T-cell function after CD6-depleted allogeneic bone marrow transplantation

RJ Soiffer, L Bosserman, C Murray, K Cochran, J Daley, J Ritz

Blood (1990) 75 (10): 2076–2084.

https://doi.org/10.1182/blood.V75.10.2076.2076

Published: 1990

Journal Articles

Studies of in vitro activated CD5+ B cells

AS Freedman, G Freeman, J Whitman, J Segil, J Daley, LM Nadler

Blood (1989) 73 (1): 202–208.

https://doi.org/10.1182/blood.V73.1.202.202

Published: 1989

Journal Articles

Normal cellular counterparts of B cell chronic lymphocytic leukemia

AS Freedman, AW Boyd, FR Bieber, J Daley, K Rosen, JC Horowitz, DN Levy, LM Nadler

Blood (1987) 70 (2): 418–427.

https://doi.org/10.1182/blood.V70.2.418.418

Published: 1987

NARROW

Pegaspargase Can Safely be Administered in Adults Age 40 and Older with Acute Lymphoblastic Leukemia

Risk of Hyponatremia and Associated Clinical Characteristics in Patients with Acute Lymphoblastic Leukemia after CD19 Targeted Chimeric Antigen Receptor (CAR) T-Cells

Biomarkers for Predicting Toxicity and Response in Adult Acute Lymphoblastic Leukemia (ALL) Patients Treated with Blinatumomab

Venetoclax Combined with Either a Hypomethylating Agent or Low-Dose Cytarabine Shows Activity in Relapsed and Refractory Myeloid Malignancies

Erwinia Asparaginase Safety and Feasibility during Therapy for Acute Lymphoblastic Leukemia in Adult Patients with Pegaspargase Hypersensitivity or Severe Toxicity

Prediction of graft-versus-host disease by phenotypic analysis of early immune reconstitution after CD6-depleted allogeneic bone marrow transplantation

Autologous and allogeneic bone marrow transplantation for poor prognosis patients with B-cell chronic lymphocytic leukemia

Follicular dendritic cells inhibit human B-lymphocyte proliferation

Clonal analysis of T-cell deficiencies in autotransplant recipients

Reconstitution of T-cell function after CD6-depleted allogeneic bone marrow transplantation

Studies of in vitro activated CD5+ B cells

Normal cellular counterparts of B cell chronic lymphocytic leukemia

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only